Back
Anebulo Pharmaceuticals Vs. Revance Therapeutics Industry Stock Comparison
Sell
23
ANEB
Anebulo Pharmaceuticals
Last Price:
1.45
Seasonality Move:
20.03%
Sell
17
RVNC
Revance Therapeutics
Last Price:
3.78
Seasonality Move:
6.97%
Sell
23
Anebulo Pharmaceuticals (ANEB)
is a Sell
Is Anebulo Pharmaceuticals a Buy, Sell or Hold?
- The current Anebulo Pharmaceuticals [ANEB] share price is $1.40. The Score for ANEB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ANEB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $4.02. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ANEB Stock Price Chart
What is Anebulo Pharmaceuticals's stock price today?
-
The Anebulo Pharmaceuticals share price today is $1.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $4.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.
ANEB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 34.17 | Sell |
| Chaikin Money Flow: | -8205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.49 - 1.85) | Sell |
| Bollinger Bands (100): | (1.69 - 2.25) | Sell |
RVNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 39.81 | Sell |
| Chaikin Money Flow: | -197589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.84 - 5.68) | Sell |
| Bollinger Bands (100): | (3.83 - 6.27) | Sell |
ANEB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Sell |
| 20-day SMA: | 1.63 | Sell |
| 50-day SMA: | 1.84 | Sell |
| 200-day SMA: | 2.28 | Sell |
| 8-day EMA: | 1.48 | Sell |
| 20-day EMA: | 1.6 | Sell |
| 50-day EMA: | 1.77 | Sell |
| 200-day EMA: | 2.14 | Sell |
RVNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.89 | Buy |
| 20-day SMA: | 4.59 | Sell |
| 50-day SMA: | 5.07 | Sell |
| 200-day SMA: | 4.58 | Sell |
| 8-day EMA: | 3.96 | Buy |
| 20-day EMA: | 4.38 | Sell |
| 50-day EMA: | 4.85 | Sell |
| 200-day EMA: | 5.97 | Sell |
Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
Anebulo Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revance Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||